Hepatitis C virus NS5B polymerase primes innate immune signaling

2Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Innate immunity controls pathogen replication and spread. Yet, certain pathogens, such as Hepatitis C Virus (HCV), escape immune elimination and establish persistent infections that promote chronic inflammation and related diseases. Whereas HCV regulatory proteins that attenuate antiviral responses are known, those that promote inflammation and liver injury remain to be identified. Here, we show that transient expression of HCV RNA-dependent RNA polymerase (RdRp), NS5B, in mouse liver and human hepatocytes results in production of small RNA species that activate innate immune signaling via TBK1-IRF3 and NF-jB and induce cytokine production, including type I interferons (IFN) and IL-6. NS5B-expression also results in liver damage. © 2013 by the American Association for the Study of Liver Diseases.

Cite

CITATION STYLE

APA

Gerold, G., & Pietschmann, T. (2013, March). Hepatitis C virus NS5B polymerase primes innate immune signaling. Hepatology. https://doi.org/10.1002/hep.26201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free